Advertisement
HCA vs MD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCA is a Hold and MD is a Hold.
HCA's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for HCA turned positive on October 08, 2026. Looking at past instances where HCA's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on HCA as a result. In 63 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
HCA moved above its 50-day moving average on September 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCA advanced for three days, in 248 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 206 of 322 cases where HCA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
HCA broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-140.595) is normal, around the industry mean (208.195). P/E Ratio (14.507) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.323) is also within normal values, averaging (2.498). Dividend Yield (0.007) settles around the average of (0.005) among similar stocks. P/S Ratio (1.264) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. HCA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Aroon Indicator for MD shows an upward move is likely
MD's Aroon Indicator triggered a bullish signal on September 21, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 195 similar instances where the Aroon Indicator showed a similar pattern. In 134 of the 195 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 69%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MD as a result. In 65 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for MD just turned positive on October 08, 2026. Looking at past instances where MD's MACD turned positive, the stock continued to rise in 30 of 45 cases over the following month. The odds of a continued upward trend are 67%.
MD moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where MD advanced for three days, in 198 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for MD crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
MD broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. MD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.392) is normal, around the industry mean (208.195). P/E Ratio (12.407) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.119) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
HCA | MD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 40 | 100 | |
SMR RATING 1..100 | 45 | 46 | |
PRICE GROWTH RATING 1..100 | 42 | 39 | |
P/E GROWTH RATING 1..100 | 63 | 38 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (9) in the Hospital Or Nursing Management industry is somewhat better than the same rating for MD (56) in the Medical Or Nursing Services industry. This means that HCA’s stock grew somewhat faster than MD’s over the last 12 months.
HCA's Profit vs Risk Rating (40) in the Hospital Or Nursing Management industry is somewhat better than the same rating for MD (100) in the Medical Or Nursing Services industry. This means that HCA’s stock grew somewhat faster than MD’s over the last 12 months.
HCA's SMR Rating (45) in the Hospital Or Nursing Management industry is in the same range as MD (46) in the Medical Or Nursing Services industry. This means that HCA’s stock grew similarly to MD’s over the last 12 months.
MD's Price Growth Rating (39) in the Medical Or Nursing Services industry is in the same range as HCA (42) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to HCA’s over the last 12 months.
MD's P/E Growth Rating (38) in the Medical Or Nursing Services industry is in the same range as HCA (63) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to HCA’s over the last 12 months.
| HCA | MD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | N/A |
| Stochastic ODDS (%) | 2 days ago 47% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 72% | 2 days ago 68% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 69% | 2 days ago 64% |
| TrendMonth ODDS (%) | 2 days ago 67% | 2 days ago 72% |
| Advances ODDS (%) | 2 days ago 71% | 3 days ago 66% |
| Declines ODDS (%) | 14 days ago 63% | 8 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 45% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 64% | 2 days ago 69% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HCA’s FA Score shows that 1 FA rating(s) are green while MD’s FA Score has 0 green FA rating(s).
- HCA’s FA Score: 1 green, 4 red.
- MD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCA’s TA Score shows that 5 TA indicator(s) are bullish while MD’s TA Score has 5 bullish TA indicator(s).
- HCA’s TA Score: 5 bullish, 4 bearish.
- MD’s TA Score: 5 bullish, 4 bearish.
Price Growth
HCA (@Hospital/Nursing Management) experienced а +7.12% price change this week, while MD (@Hospital/Nursing Management) price change was +4.76% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.34%. For the same industry, the average monthly price growth was -7.89%, and the average quarterly price growth was +17.35%.
Reported Earning Dates
HCA is expected to report earnings on Oct 27, 2026.
MD is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+0.34% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been loosely correlated with UHS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if HCA jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To HCA | 1D Price Change % | ||
|---|---|---|---|---|
| HCA | 100% | +0.47% | ||
| UHS - HCA | 66% Loosely correlated | +0.10% | ||
| THC - HCA | 62% Loosely correlated | -0.69% | ||
| ENSG - HCA | 39% Loosely correlated | -0.38% | ||
| CON - HCA | 33% Poorly correlated | N/A | ||
| SGRY - HCA | 32% Poorly correlated | +2.18% | ||
More | ||||
MD and
Correlation & Price change
A.I.dvisor tells us that MD and UHS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MD and UHS's prices will move in lockstep.